2YR企业会员
英文名称 | 中文名称 | CAS |
---|---|---|
I-BET567 | 化合物I-BET567 | 1887237-54-8 |
Raltegravir Intermediate;(Benzyl [1-[4-[[(4-fluorobenzyl)amino]carbonyl]-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]-1-methylethyl]carbamate) | [1-[4-[[(4-氟苄基)氨基]羰基]-5-羟基-1-甲基-6-氧代-1,6-二氢嘧啶-2-基]-1-甲基乙基]氨基甲酸苄酯 | 518048-02-7 |
FT113 | FT113 | 1630808-89-7 |
DSP-2230 | DSP-2230 | 1233231-30-5 |
Nifeviroc | Nifeviroc | 934740-33-7 |
2-bromo-3,4-dihydro-6-hydroxynaphthalen-1(2H)-one | 2-溴-3,4-二氢-6-羟基萘-1(2H)-酮 | 1093227-38-3 |
2-bromo-N-ethyl-5-methoxyaniline | 2-溴-N-乙基-5-甲氧基苯胺 | |
JQKD-82 | JQKD-82 | 2410512-38-6 |
ML339 | 化合物ML339 | 2579689-83-9 |
INE963 | 化合物INE963 | 2640567-43-5 |
2-(diMethylphosphoryl)aniline | 2-(二甲基氧磷基)苯胺 | 1197953-47-1 |
Raltegravir Intermediate ;Propanoic acid, 2,2-dimethyl-, 2-(1-amino-1-methylethyl)-4-[[[(4-fluorophenyl)methyl]amino]carbonyl]-1,6-dihydro-1-methyl-6-oxo-5-pyrimidinyl ester | 雷特格韦-RT9 | 1172131-64-4 |
SBI-425 | 化合物 T16859 | 1451272-71-1 |
PF-06835919 | PF-06835919 | 2102501-84-6 |
CC90001 | CC90001 | 1403859-14-2 |
ERK-IN-1 | ERK-IN-1 (COMPOUND B) | 1715025-32-3 |
BAY 2416964 | AHR antagonist 3 | 2242464-44-2 |
METHYL-D3-AMINE HYDROCHLORIDE | 氘代甲胺盐酸盐 | 7436-22-8 |
IACS-13909 | 4-Piperidinamine, 1-[3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl- | 2160546-07-4 |
Bocidelpar | 化合物BOCIDELPAR | 2095128-20-2 |
NCC007 | NCC007游离态 | 2342583-66-6 |
MIPS-521 | MIPS-521 | 1146188-19-3 |
Lu AF27139 | 5-THIAZOLECARBOXAMIDE, N-[(2S)-2-(4-CHLOROPHENYL)-2-(4-MORPHOLINYL)ETHYL]-2-(2-PYRIMIDINYL)-4-(TRIF | 2097117-06-9 |
GSK329 | 化合物 T24109 | 1268490-12-5 |
Raltegravir potassium | 雷特格韦钾盐 | 871038-72-1 |
LIXIVAPTAN | 利伐普坦 | 168079-32-1 |
HBX 41108 | 7-氯-9-氧代-9H-茚并[1,2-B]吡嗪-2,3-二甲腈 | 924296-39-9 |
GSK3145095 | GSK3145095 | 1622849-43-7 |
vanin-1 inhibitor | vanin-1 inhibitor | 2173134-00-2 |
YP001 | YP001 | 1192171-69-9 |
Complement factor D-IN-2 | 2-Azabicyclo[3.1.0]hexane-3-carboxamide, 2-[2-[3-acetyl-5-(2-methyl-5-pyrimidinyl)-1H-indazol-1-yl]acetyl]-N-(6-bromo-2-pyridinyl)-, (1R,3S,5R)- | 1903742-34-6 |
PS-5505 | PS-5505 | 2409964-23-2 |
SGK1-IN-4 | 化合物SGK1-IN-4 | 1628048-93-0 |
RS 67333 hydrochloride | RS 67333盐酸盐 | 168986-60-5 |
(2-((2,5-Dichloropyrimidin-4-yl)amino)phenyl)dimethylphosphine oxide | (2-((2,5-二氯嘧啶-4-基)氨基)苯基)二甲基膦氧化物 | 1197953-49-3 |
PF-06882961 | PF-06882961 | 2230198-02-2 |
KL1333 | KL1333 | 1800405-30-4 |
PK68 | PK68 | 2173556-69-7 |
GS-4361 | GS-4361 | 2291164-02-6 |
BMS-615 | BMS-615 | 2180127-82-4 |
MDR652 | 化合物MDR-652 | 1933528-96-1 |
BMS-986242 | Benzamide, 4-chloro-N-[(1R)-1-[cis-4-(6-fluoro-4-quinolinyl)cyclohexyl]ethyl]- | 1923844-48-7 |
FHD-286 | FHD-286 | 2671128-05-3 |
2-(4-(bromomethyl)phenyl)ethyl]carbamic acid tert-butyl ester | [2-(4-(broMoMethyl)phenyl)ethyl]carbaMic acid tert-butyl ester | 914103-95-0 |
6-chloro-2-methylpyridazin-3(2H)-one | 6-氯-2-甲基-2H-哒嗪-3-酮 | 10071-38-2 |
tert-Butyl 5-bromo-2-methylbenzoate | 2-甲基-5-溴苯甲酸叔丁酯 | 1202551-75-4 |
GSK-2894631A | GSK-2894631A | 2101626-26-8 |
BAY-218 | CPD3504 | 2162982-11-6 |
EC-5026 | EC-5026 | 1809885-32-2 |
CDK4/6-IN-6 | CDK4/6-IN-6 | 2380321-51-5 |
PF-9363 | PF-9363 | 2569009-58-9 |
Elacestrant 2HCl;RAD1901 HCl salt | RAD-1901 | 1349723-93-8 |
Seltorexant | JNJ-42847922 | 1293281-49-8 |
CC-90011 | CC-90011 | 2097523-60-7 |
Methyl-d3-p-toluenesulfonate | D3-对甲苯磺酰甲酯 | 7575-93-1 |
SHR0302 | 化合物SHR0302 | 1445987-21-2 |
AZD5305 | AZD-5305 | 2589531-76-8 |
SB-747651A dihydrochloride | SB-747651A二盐酸盐 | 1781882-72-1 |
Elacestrant | RAD-1901 | 722533-56-4 |
6-Bromo-1H-Indazole-3-Carbaldehyde | 6-溴-1H-吲唑-3-甲醛 | 885271-72-7 |
Bretazenil | 溴他西尼 | 84379-13-5 |
VU6015929 | Benzamide, 4-fluoro-3-[[[5-(1-methyl-1H-pyrazol-3-yl)-3-pyridinyl]methyl]amino]-N-[3-(trifluoromethoxy)phenyl]- | 2442597-56-8 |
SKF89976A hydrochloride | 1 - (4,4 - 二苯基-3 - 丁烯基)- 3 -哌啶盐酸盐 | 85375-15-1 |
SR1664 | 4′-[[2,3-Dimethyl-5-[[[(1S)-1-(4-nitrophenyl)ethyl]amino]carbonyl]-1H-indol-1-yl]methyl]- [1,1′-Biphenyl]-2-carboxylic acid | 1338259-05-4 |
AER-271 | AER-271 | 634913-39-6 |
NVS-ZP7-4 | NVS-ZP7-4 | 2349367-89-9 |
SPASTAZOLINE | SPASTAZOLINE | 2351882-11-4 |
DS-1971a | DS-1971a | 1450595-86-4 |
AMP-945 | AMP-945 | 1393653-34-3 |
Ximelagatran | 希美加群 | 192939-46-1 |
(tert-Butyl ((1S,2S)-2-aminocyclohexyl)carbamate) | (1S,2S)-BOC-1,2-环己二胺 | 180683-64-1 |
Azidamfenicol | 叠氮氯霉素 | 13838-08-9 |
GLUT inhibitor-1 | GLUT抑制剂1 | 2421141-40-2 |
Glutathione synthesis-IN-1 | 化合物GLUTATHIONE SYNTHESIS-IN-1 | 2632968-72-8 |
BAY-179 | 化合物BAY-179 | |
RY785 | RY785 | 1393748-80-5 |
N1,N1,2-trimethylpropane-1,2-diamine dihydrochloride | N1,N1,2-三甲基-1,2-丙二胺盐酸盐 | 75975-36-9 |
KN-62 | 1-[N,O-二(5-异喹啉磺酰基)-N-甲基-L-型酪氨酸]-4-苯基哌嗪 | 127191-97-3 |
Danicopan | Danicopan | 1903768-17-1 |
AZD-7648 | AZD-7648 | 2230820-11-6 |
LML134 | LML-134 | 1542135-76-1 |
SR-4835 | SR-4835 | 2387704-62-1 |
CA4948 | 4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)- | 1801344-14-8 |
ACH-000143 | 化合物ACH-000143 | 2225836-30-4 |
SCD1 inhibitor-3 | 化合物SCD1 INHIBITOR-3 | 1282606-48-7 |
CJ033466 | CJ 033466 | 519148-48-2 |
6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole | 6-溴-4-氟-1-异丙基-2-甲基-1H-苯并[d]咪唑 | 1231930-33-8 |
4-Fluoro-1-isopropyl-2-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole | 4-氟-1-异丙基-2-甲基-6-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)-1H-苯并[d]咪唑 | 1231930-37-2 |
Licogliflozin | 1291094-73-9 | 1291094-73-9 |
Benzetimide Hydrochloride | 盐酸苄替米特 | 5633-14-7 |
Tavapadon | Tavapadon | 1643489-24-0 |
GSK8612 | GSK8612 | 2361659-62-1 |
AT-007 | AT-007 | 2170729-29-8 |
suvn-911 | 化合物SUVN-911 | 2414674-71-6 |
EST73502 | 化合物EST73502 HCL | 2307458-82-6 |
GSK251 | GSK251 | 2125968-05-8 |
XL092 | XL092 | 2367004-54-2 |
YTX-465 | YTX-465 | 2225824-53-1 |
GLPG2938 | GLPG2938 | 2130996-00-6 |
KL11743 | KL11743 | 1369452-53-8 |
联系方式